The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival

A. Scuto, P. Krejci, L. Popplewell, J. Wu, Y. Wang, M. Kujawski, C. Kowolik, H. Xin, L. Chen, Y. Wang, L. Kretzner, H. Yu, W. R. Wilcox, Y. Yen, S. Forman, R. Jove

Research output: Contribution to journalArticlepeer-review

102 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival'. Together they form a unique fingerprint.

Medicine & Life Sciences